日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine.

肿瘤异质性是自体肾细胞癌肿瘤疫苗中多表位策略的理论依据

Wittke Stefan, Baxmann Susann, Fahlenkamp Dirk, Kiessig Stephan T

Comments on the Judgement of the Court of Justice of the European Union of April 29, 2015: Is the Permanent Exclusion of MSM from Giving Blood Compatible with the Directive 2004/33/EC? What Are the Consequences for Blood Donations in Germany?

对欧盟法院2015年4月29日判决的评论:永久禁止男男性行为者献血是否符合2004/33/EC指令?这对德国的献血有何影响?

Bakhschai, Bita; Kiessig, Stephan T

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting

在辅助治疗条件下,采用自体肿瘤裂解物疫苗治疗肾癌患者的十年生存分析

May, Matthias; Brookman-May, Sabine; Hoschke, Bernd; Gilfrich, Christian; Kendel, Friederike; Baxmann, Susann; Wittke, Stefan; Kiessig, Stephan T; Miller, Kurt; Johannsen, Manfred